MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-08-2023
Invitae Corporation DSO Ratio 2011-2025 | NVTA
Annual DSO Ratio Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 242 | 165 | 52.4 | 54.8 | 65 | 55.8 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 242 | 52.4 | 106 |
Quarterly DSO Ratio Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.3 | 64.8 | 70.7 | - | 58.7 | 54.4 | 54.1 | 45.1 | 45.5 | 39.7 | 41.1 | 43.4 | 63.4 | 94.3 | 57 | 44.8 | 52.5 | 55.5 | 66.2 | 52.9 | 64.2 | 64.3 | 60.5 | 37.4 | 52.4 | 66.3 | 51.1 | 11.4 | 16.8 | 18.9 | 13.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 94.3 | 11.4 | 50.8 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
31.7 | $ 20.5 | -4.92 % | $ 221 M |  China |
 |
Co-Diagnostics
CODX
|
101 | $ 0.23 | -2.26 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
49.2 | $ 39.2 | -0.49 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
57 | $ 230.58 | 0.1 % | $ 169 B | USA |
 |
DarioHealth Corp.
DRIO
|
85.8 | $ 10.56 | 5.18 % | $ 300 M |  Israel |
 |
BioNano Genomics
BNGO
|
83.4 | $ 1.5 | -1.07 % | $ 1.91 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Exact Sciences Corporation
EXAS
|
29.9 | $ 101.62 | 0.04 % | $ 18.8 B | USA |
 |
DexCom
DXCM
|
85 | $ 67.79 | 0.33 % | $ 26.2 B | USA |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 26.61 | -0.41 % | $ 805 M | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 19.02 | -2.36 % | $ 1.02 B | USA |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
385 | $ 3.2 | - | $ 102 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 226.58 | -0.15 % | $ 41.1 B | USA |
 |
Guardant Health
GH
|
49.2 | $ 101.62 | -1.32 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
51.3 | $ 6.35 | -2.08 % | $ 575 M | USA |
 |
ENDRA Life Sciences
NDRA
|
7.11 | $ 4.81 | -5.39 % | $ 2.58 M | USA |
 |
Neogen Corporation
NEOG
|
66.6 | $ 7.2 | 0.91 % | $ 1.56 B | USA |
 |
National Research Corporation
NRC
|
33 | $ 18.82 | 0.83 % | $ 462 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 133.99 | -0.71 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 203.2 | -0.17 % | $ 10.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
46.5 | $ 175.29 | -0.38 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 6.8 | -0.29 % | $ 882 M | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
54.1 | $ 253.12 | -0.33 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 183.24 | 0.22 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
43.6 | $ 684.16 | -0.63 % | $ 56.4 B | USA |
 |
Personalis
PSNL
|
55.8 | $ 8.02 | -1.47 % | $ 475 M | USA |
 |
Lantheus Holdings
LNTH
|
72 | $ 66.86 | 0.22 % | $ 4.63 B | USA |
 |
Quidel Corporation
QDEL
|
116 | $ 29.14 | -0.55 % | $ 1.23 B | USA |
 |
Mettler-Toledo International
MTD
|
63.7 | $ 1 415.25 | -0.36 % | $ 30 B |  Schweiz |
 |
Agilent Technologies
A
|
63.8 | $ 138.08 | -0.22 % | $ 42 B | USA |
 |
RadNet
RDNT
|
34.9 | $ 73.09 | -0.08 % | $ 5.34 B | USA |